CAS: 1257116-00-9
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
(1S,2S)-2-(1H-Benzo[D]imidazol-2-yl)-N-((R)-1-(5-(2,2,2-trifluoroethoxy)pyrazin-2-yl)ethyl)cyclopropane-1-carboxamide REF: 3D-HAC11600CAS: 1257116-00-9 | Min. 95% | Prezzo su richiesta | Mar 14 Gen 25 | |
RQ-00311651 REF: TM-T24738CAS: 1257116-00-9 | - - - | 1.579,00 €~2.647,00 € | Mar 21 Gen 25 |
(1S,2S)-2-(1H-Benzo[D]imidazol-2-yl)-N-((R)-1-(5-(2,2,2-trifluoroethoxy)pyrazin-2-yl)ethyl)cyclopropane-1-carboxamide
CAS:1257116-00-9
(1S,2S)-2-(1H-Benzo[D]imidazol-2-yl)-N-((R)-1-(5-(2,2,2-trifluoroethoxy)pyrazin-2-yl)ethyl)cyclopropane-1-carboxamide is a research tool that has been shown to be an activator of the …
Formula:
C19H18F3N5O2
Purezza:
Min. 95%
Peso molecolare:
405.4 g/mol
Ref: 3D-HAC11600
250mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 14 Gennaio 2025
RQ-00311651
CAS:1257116-00-9
RQ-00311651 is a novel T-type Ca2+ channel blocker. RQ-00311651 also inhibited high K-induced Ca signaling …
Formula:
C19H18F3N5O2
Colore e forma:
Solid
Peso molecolare:
405.37
Ref: TM-T24738
25mg | 1.579,00 € | ||
50mg | 2.061,00 € | ||
100mg | 2.647,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025